2BB score and signals
Lantern Pharma Inc.’s current 2BB score is 17 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 15 | Very Low |
| Momentum | 20 | Strongly Weakening |
| Financial strength | 0 | Very Weak |
| Quality | 40 | Normal |
| Risk | 89 | Very High |
Company facts
| Headquarters | Dallas, Texas, United States |
| Founded | 2013 |
| Employees | 16 |
| 52-week range | $0.65 – $4.58 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-29 | — | -0.4182 | — | $0.00 |
| 2026-11-11 | — | -0.357 | — | $0.00 |
| 2026-08-14 | -0.28 | -0.3876 | $0.00 | $0.00 |
| 2026-05-15 | -0.3 | -0.3672 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish